References
- 1. Leclercq R. Enterococci acquire new kinds of resistance. Clin Infect Dis. I997;24(l):580-1.
- 2. Murray BE. The life and times of the Enterococcus. Gin Microbiol Rev. 1990;3:46-65.
- 3. Werner G, GoqucTM, Hammerum AM, Hope R, Hrynicwicz W, Johnson A, ct al Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Survcill. 2008; 3 (47)pii 19046.
- 4. Willems RJ, Bonten MJ. Glyoopcptidc-resistant enterococci: deciphering virulence, resistance and cpidcmicity. Cutt Opin Infect Dis. 2007;20:384-90.
- 5. Willems RJ, Homan W, Top J.van Santten M, Tribe D, Manzioros X, ct al. Variantt?\pgcncasa marker of a distinct genetic lineage of vancomycin-resistant Entemcoccus faecium spreading in hospitals. Lancet 2001 ;357:853-5.
- 6. Willems RJ, Top J, Van Santrn M, Robinson DA, Coquc TM, Baqucro F, ct al. Global spread of vancomycin-resistant Enterococcusfaecium from distinct nosocomial genetic complex. Emcrg Infect Dis. 2005;11:821-8.
- 7. Leavis HL, Bonten MJ, Willems RJ. Identification ofhigh-risk cntrocoocal clonal complexes: global dispersion and antibiotic resistance. Girr Opin Microbiol. 2006,9:454-60.
- 8. Huyekc M, Sahm D, Gilmore S. Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emcrg Infect Dis. 1998;4:1218-31.
- 9. Keuleyan E, Srodkova M, Stefaniov I, Savov E, Borissova V, Markovska Ret al Survey on antimicrobial resistance in enterococci from human and vctcrinaiy sources. Proceedings of the XXXIII Annual Conference of Indian Pharmacological Society; 2000 December 28-30; Gandhinagar; India.
- 10. Lazarova G, Kantardjiev T, Velinov C, Rachkova K, Rukanova D, Dukova Let al. Vancomycin-resistant enterococci in hospitalized patients with urinary tract infections - first report in Bulgaria. TrakiaJ Sci.2005;3{4):13-4.
- 11. Facklam RR, CoDins MD. Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol. 1989;27(4):731-4
- 12. Devriese LA, Pot B, Kersters K, Lauwers S, Haesebrouck F. Acidification of methyl-a-D-ghioopiranosid: a useful test to differentiate Enterococcus cassehjlavus and Enterococcus Call inarum from Enterococcus faecium spoc ics.group and from Enterococcus faecalis. J Gin Microbiol. 1996;34(IO):2607-8.
- 13. Enterococcus spp. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement MI00-S22. Ginical and Laboratory Standards Institute. 2012;32(3):90-4.
- 14. Barisic Z, Punda-Polic V. Antibiotic resistance among cntcrocoocal strains isolated from clinical specimens. Int J Antimicrob Agents. 2000; 16(1)65-8.
- 15. Sader HS, Moet GJ, Jones RN. Update on the in vitro activity ofdaptomyein tested against 17,193 Gram-positive bacteria isolated from European Medical Centers (2005-2007). J Chcmothcr. 2009;2l(5):500-6.
- 16. Zouain MG, Araj GF. Antimiaobial resistance of enterococci in Lebanon. Int J Antimicrob AgenU. 2001;17(3):209-13.
- 17. Entcrocooci. Annual report of the European Antimiaobial Resistance Surveillance Network. (EARS-Net). Stockholm, ECDC, 2010. p. 33-7.
- 18. Aznar J, Lepe JA, Dowacky M. Antimiaobial susceptibility among £ faecal is and £. faecaim from France, Germany, Italy, Spain and the UK (T.E.S.T. Surveillance Study,2004-2009) J Chcmothcr. 20l2;24(2):74-80.
- 19. Torell E, Cars O, Olsson-LijcquistB, Hoffman B, Lindback J, Butman LG and The Entaoooccal Study Group. Near absence of vancomycin-resistant enterococci but high catTbge rates of quinoloncs-rcsistant ampicillin-rcsistant enterococci among hospitalized patients and nonhospitalized individuals in Sweden. J Clin Microbiol. 1999;37:3509-13.
- 20. Torell E, Cars O, Hambracus A. Ampicillin-rcsistant enterococci in a Swedish University Ho<pital; nosocomial spread and risk-factors for infection. ScandJ Infect Dis. 2001;33: 182-7.
- 21. Leavis HL, Willems RJ.Top J, Bonten MJ. High-level ciprofloxacin resistance from point mutations in gyrA and parC oonfinod to global hospital-adapted clonal lineage CCI7 of Enterococcusfaeciunt J Clin Microbiol. 2006;44: 1059-64.
- 22. Torell E, Kuhn I, Olsson-Lijequist B, Haeggman S, Hoffman B-M, Lindahl C, Burman LG. Clonality among ampicillin-rcsistant Enterococcus faecium isolates in Sweden and relationship with ciprofloxacin resistance. Clin Miaobiol Infect. 2003;9; 1011-9.
- 23. Shoutcn MA, Moss A, Hoogkamp-Korstanjc JA. Antimicrobial susceptibility patterns of cnterocooci causing infections in Europe. The European VRE Study Group. Antimicrob AgenU Chcmothcr. 1999;43:2542-6.
- 24. Hallgren A, Abednazari H, Ekdahl C, Hanbenger H, Nilsson M, Samuelssona A, at al. Antimicrobial susceptibility patterns of cnterocooci in intensive care uniU in Sweden evaluated by diffaent MIC breakpoint systems. J AntimiaobChemolher. 2001 ;4 833-62.
- 25. Sredkova M. Resistance to penicillins, aminoglycosides and vancomycin in cnterocooci isolated from clinical specimens. Infoctology. 1999,36(2): 18-21. [In Bulgarian],
- 26. Thapa B, Tattawasart U, Manjai A, Chantarasuk Y. Antimiaobial resistance and species prevalence of cterocoocal isolates in Srinagarind Hospital, Northeastern Thailand KKU Res J (GS). 20I2;7 (4):97-107.
- 27. Butcu M, Akcay SS, Inan AS, Aksaray S, Engin IX), Calisid G. In vitro susceptibility of cnterocooci strains isolated from urine samples to fosfomycin and other antibiotics. J Infect Chcmothcr. 2011; 17(4):575-8.
- 28. Salem-Bekhit MM, Moussa L Muharram MM, Alanazy FK, Hefiti HM. Prevalence and antimiaobial resistance pattern of multidrug-rcsistant cntrcrococci isolated from clinical specimens. Indian J Med Microbiol. 2012;30( I );44-51.
- 29. Frazzon A, Gama BA, Hames V, Bierhals CG, Pereira RL Gucdcs AG ct al. Prevalence of antimicrobial resistance and molecular characterization of tetracycline resistance mediated by ref (M) and let (L) genes in Enterococcus spp. isolated from food in Southan Brasil. World J Microbiol Biotochnol. 2010; 26; 365-70.
- 30. Quinones D, Goni P, Rubio MC, Duran E, Gomez-Lus R. Enterococcus spp. isolated from Cuba; species frequency of occurrence and antimicrobial susceptibility profile. Diagn Microbiol Infect Dis. 2005;51(l):63-7.
- 31. Zhanel GG, Hoban DJ, Karlowsky JA. Nitrofurantoin is active against vancomycin-resistant enterococci. Antimicrob Agents Chcmothcr. 2001 ;45( I ):324-6.